Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT) - Adventist HealthCare

Clinical Trial Details

RE-CIRCUIT

Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT)

Purpose/Objective

Request Additional Trial Information
Full Trial Details: ClinicalTrials.gov

Condition: Atrial Fibrillation
Study Type: Interventional
Phase: Phase IV
Study Start Date: 02/03/2016
Study Completion Date: 05/31/2017

This study is to assess the safety of an uninterrupted dabigatran etexilate periprocedural anticoagulant regimen compared to an uninterrupted warfarin regimen in NVAF patients undergoing AF ablation.

NCT Number
NCT02348723
Principal Investigator(s)
Sean Beinart, MD
Sponsor(s)
Boehringer Ingelheim
Participant Eligibility
  • Age: 18 - No Maximum
  • Gender: Male, Female

Location

  • Adventist HealthCare Washington Adventist Hospital
    7600 Carroll Avenue
    Takoma Park, MD 20912
    Main: 301-891-7600

Find a Doctor

Find an Adventist HealthCare affiliated doctor by calling our FREE physician referral service at 800-642-0101 or by searching our online physician directory.

View Doctors

Set Your Location

Setting your location helps us to show you nearby providers and locations based on your healthcare needs.